Cidara Therapeutics, Inc. (CDTX)
220.86
+0.01
(+0.00%)
USD |
NASDAQ |
Dec 23, 16:00
220.85
-0.01
(-0.00%)
Pre-Market: 20:00
Cidara Therapeutics SG&A Expense (TTM): 28.09M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Merck & Co., Inc. | 10.70B |
| Mersana Therapeutics, Inc. | 31.53M |
| Bristol Myers Squibb Co. | 7.222B |
| Johnson & Johnson | 23.38B |
| Pfizer Inc. | 13.91B |